Search

Your search keyword '"Miolo, G."' showing total 313 results

Search Constraints

Start Over You searched for: Author "Miolo, G." Remove constraint Author: "Miolo, G."
313 results on '"Miolo, G."'

Search Results

1. Assessing the physicochemical stability and intracellular trafficking of mRNA-based COVID-19 vaccines

4. Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer

5. P-246 Taxane cross-resistance: An exploratory analysis of second-line chemotherapy for metastatic gastric cancer

6. P-266 LDH levels as predictors of efficacy in second-line treatment for metastatic gastric cancer: The LINE study

8. Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer

10. Photodegradation of Drugs of Abuse in Hair

12. The SAFFO study: Sex-related prognostic role and cut-oFf deFinition of monocyte-to-lymphocyte ratio (MLR) in metastatic colOrectal cancer

13. THE SLICE STUDY: THE PROGNOSTIC ROLE OF VISCERAL FAT IN METASTATIC COLORECTAL CANCER

14. SUN-PO094: The Role of Nutritional Interventions in Surgically Treated Pancreatic Cancer Patients: Comparative Efficacy in a Network Meta-Analysis (NMA)

16. The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA)

17. Monocyte-to-lymphocye ratio (MLR) and LDH level in metastatic colorectal cancer (mCRC) patients (pts)

19. The SENECA study: Prognostic role of serum biomarkers in elderly metastatic colorectal cancer patients

20. The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer

21. Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition

23. Cover Image, Volume 51, Issue 2

27. Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy

32. Polymorphism of CDH1 Promoter Is a Predictor of Clinical Outcome in Patients with Metastatic Gastric Cancer Treated with chemotherapy

38. Pre-emptive pharmacogenetic testing implementation for chemotherapy dosage optimization: the translational experience at CRO of Aviano

39. Improved Natural Killer cell activity and retained anti-tumor CD8+ T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy

50. Selecting for BRCA1 testing using a combination of homogeneous selection criteria and immunohistochemical characteristics of breast cancers

Catalog

Books, media, physical & digital resources